A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Double blind, crossover randomized, multicentric study to compare efficacy and tolerability of concomitant administration of travoprost and brinzolamide versus timolol-dorzolamide fixed combination in patients with glaucoma or ocular hypertension

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Brinzolamide; Dorzolamide; Ophthalmic Solutions; Timolol; Travoprost

Criteria

Inclusion Criteria:

• Written informed consent

• Diagnosis of bilateral Primary open angle glaucoma or ocular hypertension

• Intra Ocular Pressure above 19 millimeters mercury at screening visit at 8:00 AM

• Stable visual field in last 6 months

• 6 weeks wash out from previous topical medications

Exclusion Criteria:

• Age